Cargando…
Clinical efficacy of the enzyme replacement therapy in patients with late-onset Pompe disease: a systematic review and a meta-analysis
In patients with late-onset Pompe disease (LOPD), the efficacy of the enzyme replacement therapy (ERT) with recombinant human alpha-glucosidase (rhGAA) is difficult to evaluate, due to the clinical heterogeneity and the small sample sizes in published studies. Therefore, we conduct a systematic lite...
Autores principales: | Sarah, Berli, Giovanna, Brandi, Emanuela, Keller, Nadi, Najia, Josè, Vitale, Alberto, Pagnamenta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782782/ https://www.ncbi.nlm.nih.gov/pubmed/33851281 http://dx.doi.org/10.1007/s00415-021-10526-5 |
Ejemplares similares
-
Enzyme replacement therapy and antibodies in late-onset Pompe disease
por: Schneider, I., et al.
Publicado: (2014) -
The impact of interrupting enzyme replacement therapy in late-onset Pompe disease
por: Wenninger, Stephan, et al.
Publicado: (2021) -
A Systematic Review and Meta-Analysis of Enzyme Replacement Therapy in Late-Onset Pompe Disease
por: Dornelles, Alícia Dorneles, et al.
Publicado: (2021) -
Standardized nursing management of enzyme replacement therapy for late-onset Pompe disease
por: Tang, Shan, et al.
Publicado: (2021) -
Muscle Proteomic Profile before and after Enzyme Replacement Therapy in Late-Onset Pompe Disease
por: Moriggi, Manuela, et al.
Publicado: (2021)